Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Dransfield

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 26, 2024
Editorial-2014-2024: Celebrating 10 Years of Nonprofit, Open-Access Publishing Focused on COPD, Bronchiectasis, and Nontuberculous Mycobacteria ResearchMark T Dransfield
Clinics in Chest Medicine|August 18, 2020
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and RisksTakudzwa Mkorombindo, Mark T Dransfield
Lancet (London, England)|May 13, 2023
The Lancet COPD Commission: broader questions remain - Authors' replyMark T Dransfield, Daiana Stolz
Respirology (Carlton, Vic.)|January 12, 2021
COPD: COagulation-associated Pulmonary Disease?Takudzwa Mkorombindo, Mark T Dransfield
American Journal of Respiratory and Critical Care Medicine|February 4, 2020
Predicting Pneumonia in Chronic Obstructive Pulmonary Disease. Have We Unraveled the Network of Risks?Mark T Dransfield, Dave Singh
Current Opinion in Pulmonary Medicine|December 12, 2023
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practiceTetsuro Maeda, Mark T Dransfield
NEJM Evidence|April 30, 2025
Mepolizumab in COPD - If at First You Don't SucceedMark T Dransfield, Daiana Stolz
Respirology (Carlton, Vic.)|August 22, 2019
COPD exacerbations and MACE: More than a chance encounter?Takudzwa Mkorombindo, Mark T Dransfield
International Journal of Chronic Obstructive Pulmonary Disease|September 10, 2019
Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary diseaseTakudzwa Mkorombindo, Mark T Dransfield
The Journal of Family Practice|November 14, 2018
Interpreting Recent Developments in COPD TreatmentsSanjay Sethi, Mark T Dransfield
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 26, 2024
Editorial-2014-2024: Celebrating 10 Years of Nonprofit, Open-Access Publishing Focused on COPD, Bronchiectasis, and Nontuberculous Mycobacteria ResearchMark T Dransfield
Clinics in Chest Medicine|August 18, 2020
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and RisksTakudzwa Mkorombindo, Mark T Dransfield
Lancet (London, England)|May 13, 2023
The Lancet COPD Commission: broader questions remain - Authors' replyMark T Dransfield, Daiana Stolz
Respirology (Carlton, Vic.)|January 12, 2021
COPD: COagulation-associated Pulmonary Disease?Takudzwa Mkorombindo, Mark T Dransfield
American Journal of Respiratory and Critical Care Medicine|February 4, 2020
Predicting Pneumonia in Chronic Obstructive Pulmonary Disease. Have We Unraveled the Network of Risks?Mark T Dransfield, Dave Singh
Current Opinion in Pulmonary Medicine|December 12, 2023
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practiceTetsuro Maeda, Mark T Dransfield
NEJM Evidence|April 30, 2025
Mepolizumab in COPD - If at First You Don't SucceedMark T Dransfield, Daiana Stolz
Respirology (Carlton, Vic.)|August 22, 2019
COPD exacerbations and MACE: More than a chance encounter?Takudzwa Mkorombindo, Mark T Dransfield
International Journal of Chronic Obstructive Pulmonary Disease|September 10, 2019
Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary diseaseTakudzwa Mkorombindo, Mark T Dransfield
The Journal of Family Practice|November 14, 2018
Interpreting Recent Developments in COPD TreatmentsSanjay Sethi, Mark T Dransfield
Pageof 32